How orforglipron compares to other oral GLP-1 options Orforglipron is not the only oral GLP-1 option in development or on the market
It activates GLP-1 receptors to reduce appetite and slow gastric emptying, along with GIP receptors to improve insulin sensitivity
PIONEER 7 investigators
And again, I don't know if I talked to you about this on this podcast
The differentiation of adipose precursor cells consists of two stages, the former stage is the differentiation of adipose precursor cells into immature adipocytes, and the latter stage is the transformation of immature adipocytes to mature adipocytes, which associated genes include PPAR, C/EBP, adipocyte fatty acid-binding protein (AP2), lipoprotein lipase (LPL), etc
It also slows down how quickly food leaves your stomach, leading to a prolonged feeling of fullness, which in turn helps reduce overall food intake and promotes weight loss